DOI: 10.1097/IAE.0b013e3181f36cc5
,
Issn Print: 0275-004X
Publication Date: 2010/10/01
Facebook
Twitter
LinkedIn
Email
 |
Checking for direct PDF access through Ovid | |
Excerpt
We read with great interest the article by Hidayet et al “The results of intravitreal bevacizumab injections for persistent neovascularization in proliferative retinopathy after photocoagulation therapy.”1 We value the authors for the novel method used for assessing the size of the neovascularization (NV) by marking out the area on a red free photograph and shading it blue. Also, the concept of taking the final area in pixels is extremely accurate and objective. But certain issues in this article need more clarity:
We look forward to the authors elucidating on these issue for the benefit of the readers.
